Allied Market Research
Loading...
0
Allied Market Research

Tumor Necrosis Factor Inhibitor Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

A10441
Pages: NA
Aug 2021 | 152 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Tumor Necrosis Factor Inhibitor Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

Request Now !

A Tumor Necrosis Factor inhibitor is a pharmaceutical drug used to destroy the physiologic response to tumor necrosis factor such as inflammatory response caused by TNF cytokines. A major component of the autoimmune system such as TNF- alpha is responsible for inflammation in the body. TNF inhibitors are antibodies made in a lab from human or animal tissue. Once they're put into human blood, they cause a reaction in immune system that blocks inflammation. Immune system makes a substance called tumor necrosis factor (TNF). If the body start making too much TNF, and that leads to inflammation. Inflammation that's out of control can damage body and might have pain or swelling. These drugs block the action of TNF. TNF inhibitor  widely used for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, crohn’s disease, cancer, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma. Recently, five inhibitors are available in the tumor necrosis factor inhibitor market such as Etanercept (Enbrel), Infliximab (Remicade), Adalimumab (Humira), Certolizumab (Cimzia), and Golimumab (Simponi). These are prescribed only for autoimmune diseases such as rheumatoid arthritis, crohn’s disease, and psoriasis. But this TNF inhibitors have many side effect like redness, burning, or itching where the needle goes into skin and Other possible side effects such as Coughing, Headaches, Heartburn, Nausea or vomiting, Stomach pain, Weakness. This factors hamper the market growth. 

Tumor-Necrosis-Factor-Inhibitor

Market scope and structure analysis:

Report Metric

Details

  Market size available for years

  2020–2027

  Base year considered

  2019

  Forecast period

  2021–2027

  Forecast units

  Value ($USD)

  Segments covered

  Product, Application, Distribution Channel

  Region covered

North America (U.S., Canada), Europe (U.K, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and Rest of Asia-Pacific), LANTAM (Brazil, Mexico, Argentina and Rest of Latin America), Middle East & Africa (South Africa, Suadi Arabia and UAE)

  Companies covered

Major players analyzed include, AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., UCB S.A., Novartis International AG, Pfizer, Inc.,  Merck & co., Inc., Sanofi S. A, Bristol-Myers Squibb Company, Cadila Healthcare Ltd, and GlaxoSmithKline plc.

 

COVID-19 Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

 As the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries across the globe with the “World Health Organization” announcing it a public health emergency. The global impacts of the COVID-19 pandemic are already starting to be felt, and will significantly affect the tumor necrosis factor inhibitor market in 2020. COVID-19 can affect the global economy in three main ways by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Humira hold the largest market share and continues to be one of the top-selling pharmaceutical products across the globe. According to WHO, Humira is anticipated to be at top of the TNF inhibitor products through to 2026.

Globally, North America hold the largest market share due to the strong commercial sales of TNF inhibitors in U.S. other factors contributing to the growth such as the presence of market player, increasing number of government initiative, favourable reimbursement policies, and increasing patient pool. Whereas, Asia Pacific is expected to expand the largest market share, increasing development in economic, increasing autoimmune disease, increasing development in healthcare infrastructure, growing in customer awareness, increasing geriatric population, 

In 2017 “Centers for Disease Control and Prevention” (CDC), stated that approximately 54.4 million people are suffering from arthritis in the U.S. as per the report of “National Center for Biotechnology Information” (NCBI), 50% of the population suffering from autoimmune diseases across the globe, discontinue the use of TNF inhibitors after one year of use as only 5-10% of the population showed positive response to TNF inhibitors while the remaining people show disease activity or severe side effects even after the treatment with TNF inhibitors.

The factor that drive the tumor necrosis factor inhibitor market such as increasing number of new product launches, growing prevalence of autoimmune diseases, increasing geriatric population, favourable government initiative, rising investment in R&D, and healthcare sector, increasing awareness among the population regarding tumor necrosis factor (TNF), rising demand for advanced product for treating autoimmune disease, increasing R&D activities. However the factor such as high cost of treatment and product of rheumatoid arthritis, low number of R&D activities restrain the growth of tumor necrosis factor inhibitor market. The opportunities available for tumor necrosis factor inhibitor market such as in favourable government initiative by introducing reimbursement policies, increasing R&D activities for launching advanced product, rising awareness amongst the people regarding technologically advanced treatment and product development.  

New Product launch to flourish the market:

Major Key market manufacturer have been focusing on increasing research and development activities and producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. Humaira is the most widely prescribed drug for tumor and rheumatoid arthritis disorders. Various biosimilar versions of Humira, Enbrel, and Remicade have been launched such as Erelzi, Inflectra, Cyltezo, Flixabi, Zessly, Hyrimoz, and Amgevita.  

In 2019, “Celgene Corporation” has received the U.S. FDA approval for “Otezla” an oral PDE4 inhibitor for the treatment of adult patients with mouth ulcers associated with behçet’s disease, a rare disorder that causes blood vessel inflammation throughout the body. Otezla is the first drug to be approved for this use in the U.S., providing a treatment option for behçet’s disease, many of whom develop mouth ulcers as a result of the condition.

In 2019, “Novartis AG has launched” “Etanercept- Szzs” is a biosimilars of “Etanercept manufactured by “Amgen” this biosimilar used for the treatment of autoimmune disorders. 

In 2019, “Samsung Bioepis Co., Ltd,” has recived U.S.FDA approval for “Eticovo”. This is the second biosimilar of Enbrel, which is beneficial for patients suffering from arthritis and cannot work properly with their limbs. 

In 2018, “Merck & Co.” has launched “Renflexis” biosimilar of infliximab. This biosimilar is used to treat various types of arthritis such as rheumatoid arthritis, arthritis of the spine, psoriatic arthritis, certain bowel diseases including Crohn's disease, ulcerative colitis and a certain severe skin disease including chronic plaque psoriasis.

In 2017, “Pfizer Inc.” has launched “Xeljanz” a Janus kinase inhibitor which is a small molecular drug for rheumatoid arthritis.

In 2019, “Amgen Inc.” also announced the U.S. FDA approval for “AVSOLA”.  AVSOLA is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. AVSOLA is indicated for reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage, and improving physical function in patients with psoriatic arthritis.

Key segments covered:

Segments

Sub-segments

  Product

  • Humira
  • Enbrel
  • Remicade
  • Simponi/Simponi Aria
  • Cimzia
  • Biosimilar

  Application

  • Rheumatoid Arthritis
  • Psoriasis
  • Psoriatic Arthritis
  • Crohn’s Disease
  • Ulcerative Colitis
  • Ankylosing Spondylitis
  • Juvenile Idiopathic Arthritis
  • Hidradenitis Suppurativa
  • Others

  Distribution Channel

  • Hospital Pharmacies
  • Specialty Pharmacies
  • Online Pharmacies

 

Key benefits of the report:

  • This study presents the analytical depiction of the global tumor necrosis factor inhibitor market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global tumor necrosis factor inhibitor market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global tumor necrosis factor inhibitor market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global tumor necrosis factor inhibitor market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Tumor Necrosis Factor Inhibitor Market research report:

  • Who are the leading market players active in tumor necrosis factor inhibitor market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the tumor necrosis factor inhibitor market?
  • What are the projections for the future that will help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Tumor Necrosis Factor Inhibitor Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers